Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hatch and mail order

Executive Summary

The Pharmaceutical Care Management Association and Merck-Medco have contacted Sen. Hatch's (R-Utah) office to discuss concerns about mail order pricing aired by Hatch during a Senate Finance Committee hearing on Medicare drug coverage April 24. "I know of certain circumstances where it is significantly cheaper to get the 30-day prescription filled [at retail] than it is to order a three-month supply through a mail-order plan," Hatch said, displaying a staffer's receipts for generic tetracycline, which cost $1.45 to fill at retail and $12 for a three-month mail supply. "I'm a strong supporter of PBMs, but I also believe that these are important questions that need to be addressed"

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel